on 3 Aug 2022
Last Applicant/ Owned by
XERIS PHARMACEUTICALS INC.
180 N LaSalle Street, Suite 1810Chicago, IL 60601
US
Serial Number
1936993 filed on 19th Dec 2018
Registration Number
TMA1136796 registered on 3rd Aug 2022
Registration expiry Date
3rd Aug 2032Correspondent Address
NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.
3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY
ALBERTA
CA
T2P4H2
Trademark usage description
pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmac Read More11
11
1936993
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 190 on 15th Jun 2022 | Registration Pending |
Submitted for opposition 191 on 15th Jun 2022 | Registration Fee Notice Sent |
Submitted for opposition 42 on 23rd Mar 2022 | Advertised |
Submitted for opposition 26 on 22nd Feb 2022 | Approved |
Submitted for opposition 27 on 22nd Feb 2022 | Approval Notice Sent |
Submitted for opposition 22 on 16th Feb 2022 | Search Recorded |
Submitted for opposition 88 on 27th May 2020 | Security Interest Placed |
Submitted for opposition 31 on 28th Dec 2018 | Formalized |
Submitted for opposition 30 on 19th Dec 2018 | Filed |
Submitted for opposition 1 on 19th Dec 2018 | Created |